SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: Cacaito who wrote (9497)4/1/1999 12:46:00 PM
From: Bluegreen  Respond to of 17367
 
Cacaito, reminded me of a trial for a heart medication recently where the control was WAXING the treatment group!LOL I mean really blowing the doors off the treatment group.LOL They actually presented the findings at a scientific meeting!



To: Cacaito who wrote (9497)4/1/1999 12:59:00 PM
From: Robert K.  Read Replies (2) | Respond to of 17367
 
Dr C. >you really ought to order the endotoxin article from xoma.
IMO its a right on the money (so to speak). In any case EM says it will be on the website within weeks, but you know how that story goes..
Regarding meningo patent, EM says "of course its ours" but dont expect a PR on it. Its value is determined by the outcome of the ongoing trial.
Standard K disclaimers.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News